Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating bendamustine hydrochloride injection for indolent B-cell non-Hodgkin's lymphomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indolent B-cell Non-hodgkin Lymphoma

Drugs mentioned

• Bendamustine hydrochloride injection (bendamustine hydrochloride)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Indolent B-Cell Non-Hodgkin's Lymphomas | Phase 2 | Status: COMPLETED